DNA Methylation Signatures as Early Epigenetic Biomarkers of Metabolic Risk in Obesity

Obesity is a multifactorial metabolic disorder influenced by genetic, environmental, and lifestyle factors, raising the chance of developing type 2 diabetes (T2D), cardiovascular diseases, and metabolic syndrome. DNA methylation, in particular, is one of the epigenetic mechanisms that play an important role in linking environmental exposures to changed expression of genes and metabolic dysfunction. This mini‑review highlights DNA methylation's potential signatures as early biomarkers of metabolic risk in obesity. DNA methylation is the addition of methyl groups to cytosine residues, altering gene expression without changing the DNA sequence. Altered methylation patterns in genes such as Leptin (LEP), Adiponectin (ADIPOQ), Proopiomelanocortin (POMC), Neuropeptide Y (NPY), Peroxisome Gamma Coactivator 1‑Alpha (PGC1A), and Hypoxia Inducible Factor 3 Subunit Alpha (HIF3A) have been linked to insulin resistance, obesity, energy imbalance, and inflammation. These changes may help identify individuals at risk of developing obesity‑related metabolic complications. Furthermore, DNA methylation is potentially reversible and can be influenced by dietary modifications, physical activity, and weight reduction, making it a promising target for preventive and personalised interventions. However, tissue‑specific variations and differences in study populations remain challenges. Additional long‑term research is needed to validate reliable DNA methylation signatures and establish their clinical utility in early metabolic risk prediction and personalised obesity management.

Authors

Publication Details

Journal
Indo-American Journal of Life Sciences and Biotechnology
Published
2026-11-20
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

DNA Methylation Signatures as Early Epigenetic Biomarkers of Metabolic Risk in Obesity

Asha Prabhu, Chethana Y K, Mamatha B V, Nishitha Clamenteen Salins et al.
Indo-American Journal of Life Sciences and Biotechnology
Epigenetics and DNA Methylation
article

DNA Methylation Signatures as Early Epigenetic Biomarkers of Metabolic Risk in Obesity

Asha Prabhu, Chethana Y K, Mamatha B V, Nishitha Clamenteen Salins, Chaithra D
article en

Abstract

Obesity is a multifactorial metabolic disorder influenced by genetic, environmental, and lifestyle factors, raising the chance of developing type 2 diabetes (T2D), cardiovascular diseases, and metabolic syndrome. DNA methylation, in particular, is one of the epigenetic mechanisms that play an important role in linking environmental exposures to changed expression of genes and metabolic dysfunction. This mini‑review highlights DNA methylation's potential signatures as early biomarkers of metabolic risk in obesity. DNA methylation is the addition of methyl groups to cytosine residues, altering gene expression without changing the DNA sequence. Altered methylation patterns in genes such as Leptin (LEP), Adiponectin (ADIPOQ), Proopiomelanocortin (POMC), Neuropeptide Y (NPY), Peroxisome Gamma Coactivator 1‑Alpha (PGC1A), and Hypoxia Inducible Factor 3 Subunit Alpha (HIF3A) have been linked to insulin resistance, obesity, energy imbalance, and inflammation. These changes may help identify individuals at risk of developing obesity‑related metabolic complications. Furthermore, DNA methylation is potentially reversible and can be influenced by dietary modifications, physical activity, and weight reduction, making it a promising target for preventive and personalised interventions. However, tissue‑specific variations and differences in study populations remain challenges. Additional long‑term research is needed to validate reliable DNA methylation signatures and establish their clinical utility in early metabolic risk prediction and personalised obesity management.

Indo-American Journal of Life Sciences and Biotechnology
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon